Search
for
Sort by
Research 30 of 1000+
- COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
- Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
- Repurposing of drugs as novel influenza inhibitors from clinical gene expression infection signatures
- The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
- Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19
- Lilly arthritis drug approved for alopecia
- La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Regulatory, Ethical, and Safety Considerations of Exosome‐Based Therapies in Dermatology
- What to Look for in Red Light Therapy: A Product Guide Backed by Science
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- The effect of canakinumab on clinical outcomes in patients with COVID-19: A meta-analysis
- Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic review
- Lipolytic agents for submental fat reduction: Review
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- 448 Challenges of securing insurance approval for oral tofacitinib treatment of alopecia areata: A multi-institutional retrospective review
- Current Concepts and Translational Uses of Platelet Rich Plasma Biotechnology
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Nanocarriers as Active Ingredients Enhancers in the Cosmetic Industry—The European and North America Regulation Challenges
- Microneedling in Hair Loss Treatment: Traditional Review
- Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis
- Milagros enterprise Group S.A.S.: high-quality products in hair health international business plan
- Encapsulación en ciclodextrinas de compuestos con actividad frente a la alopecia androgénica masculina.
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Medication Repurposing: New Uses for Old Drugs
- Consumer Acceptance and Market Potential of Natural Organic Cosmetic Formulations in the US Market